Legacy for Children, an Early Intervention Study to Promote Optimal Child Development in Low-Income Families
The purpose of this study is to determine if an intervention focused on promoting parent-child interaction, parental responsibility, parental commitment of time and energy, and sense of community results in better developmental outcomes for low-income children...
Brief Summary
Official Title: “Legacy for Children, The CDC Parenting Research Projects”
The purpose of this study is to determine if an intervention focused on promoting parent-child interaction, parental responsibility, parental commitment of time and energy, and sense of community results in better developmental outcomes for low-income children.
- Study Type: Interventional
- Study Design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention
- Study Primary Completion Date: October 2009
Detailed Clinical Trial Description
The early years of life (birth to age 5 years) are crucial in a child's development. Parents play a critical role in their children's development and are responsible for the environment in which they grow up. Past research shows that the personal characteristics of successful children consistently correlate to parental influences and behavior. Thus, the theoretical foundation in the Legacy study is that parents can positively influence their child's development. Also, parents are more likely to maintain positive parenting behaviors if they are part of a community greater than themselves. Legacy intervention activities are designed to enhance sensitive and responsive parenting, parent/child interaction, and promote a sense of community. Other activities include verbal and cognitive stimulation through parent and parent/child group meetings, visits to the home, and participation in community events. Legacy has both a pilot phase and a main study phase. There are 180 intervention and 120 comparison families in the main study phase and 60 of each in the pilot phase at each study site, Miami and Los Angeles. The 720 participating families are those whose children, on average, would be expected to fall below national norms on a range of developmental outcomes. Process, cost, and short- and long-term outcome data are being collected.
Comparison group: In addition to the current standard of care, the comparison families receive regular comprehensive child development and maternal assessments at 6 months, 1 yr, 2 yr, 3 yr, 4 yr, and 5 yr.
Intervention(s) in this Clinical Trial
- Behavioral: Parenting group
- Weekly and periodic (10 weeks blocks with 6 week break) parenting group meetings (2.5-3 hr), periodic one-on-one meetings (2 hr), visits to community resources (2-3 hr per event). Legacy intervention activities are designed to enhance sensitive and responsive parenting, parent/child interaction, and promote a sense of community. Other activities include verbal and cognitive stimulation through parent and parent/child group meetings, visits to the home, and participation in community events.
Arms, Groups and Cohorts in this Clinical Trial
- Experimental: 1
- Parenting group
Outcome Measures for this Clinical Trial
Primary Measures
- child behavior
- Time Frame: 1yr, 2 yr, 3 yr, 4 yr, 5 yr
Safety Issue?: No
- Time Frame: 1yr, 2 yr, 3 yr, 4 yr, 5 yr
- child social skills
- Time Frame: 1yr, 2 yr, 3 yr, 4 yr, 5 yr
Safety Issue?: No
- Time Frame: 1yr, 2 yr, 3 yr, 4 yr, 5 yr
- child cognition
- Time Frame: 1 yr, 3 yr, 5 yr
Safety Issue?: No
- Time Frame: 1 yr, 3 yr, 5 yr
- child language/communication
- Time Frame: 2 yr, 4 yr, 5 yr
Safety Issue?: No
- Time Frame: 2 yr, 4 yr, 5 yr
- child attachment
- Time Frame: 2 yr
Safety Issue?: No
- Time Frame: 2 yr
- child peer relationships
- Time Frame: 5 yr
Safety Issue?: No
- Time Frame: 5 yr
- child academics
- Time Frame: 4 yr, 5 yr
Safety Issue?: No
- Time Frame: 4 yr, 5 yr
- parent-child interaction
- Time Frame: 6 months, 5 yr
Safety Issue?: No
- Time Frame: 6 months, 5 yr
Secondary Measures
- child physical growth
- Time Frame: baseline, 6 month, 1 yr, 2 yr
Safety Issue?: No
- Time Frame: baseline, 6 month, 1 yr, 2 yr
- child violence exposure
- Time Frame: 2 yr, 4 yr, 5 yr
Safety Issue?: No
- Time Frame: 2 yr, 4 yr, 5 yr
- parenting
- Time Frame: baseline, 6 mos, 2 yr, 3 yr 5 yr
Safety Issue?: No
- Time Frame: baseline, 6 mos, 2 yr, 3 yr 5 yr
- maternal health
- Time Frame: baseline, 1 yr 3 yr, 5 yr
Safety Issue?: No
- Time Frame: baseline, 1 yr 3 yr, 5 yr
- maternal mental health
- Time Frame: baseline, 1yr, 2yr, 3yr, 4 yr, 5 yr
Safety Issue?: No
- Time Frame: baseline, 1yr, 2yr, 3yr, 4 yr, 5 yr
- sense of community
- Time Frame: baseline, 1yr, 2yr, 3yr, 4 yr, 5 yr
Safety Issue?: No
- Time Frame: baseline, 1yr, 2yr, 3yr, 4 yr, 5 yr
- community involvement
- Time Frame: baseline, 6 mos, 2yr, 3yr, 5 yr
Safety Issue?: No
- Time Frame: baseline, 6 mos, 2yr, 3yr, 5 yr
- coping
- Time Frame: 6mos, 2yr, 3 yr, 5 yr
Safety Issue?: No
- Time Frame: 6mos, 2yr, 3 yr, 5 yr
- HOME environment
- Time Frame: 1 yr
Safety Issue?: No
- Time Frame: 1 yr
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- English speaking
- Live within 10 miles of UCLA
- 18 years of age or older
- Receive their prenatal and well-baby care from MediCal
- Live within 50 minutes of the three community intervention sites
- Reside within zip codes corresponding to the lowest performing schools in the broad
- Miami area
- Give birth to the target child at participating hospitals
Exclusion Criteria:
- Multiple birth greater than twins
- Existing Substance abuse
- Existing Mental Health issues
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: 18 Years
Maximum Age for this Clinical Trial: N/A
Are Healthy Volunteers Accepted for this Clinical Trial?: Accepts Healthy Volunteers
Clinical Trial Investigator Information
Lead Investigator: Centers for Disease Control and Prevention U.S. Fed
Overall Clinical Trial Officials and Contacts
Ruth Perou, PhD Principal Investigator Centers for Disease Control and Prevention
Additional Information
Information obtained from ClinicalTrials.gov on February 12, 2012
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00164697
Study ID Number: CDC-NCBDDD-2524
ClinicalTrials.gov Identifier: NCT00164697
Health Authority: United States: Federal Government
Click here for information about this study: Legacy for Children
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00164697
